The single-use bioprocessing market covers disposable, polymer-based systems used to manufacture biologics, replacing or complementing traditional stainless-steel equipment in upstream and downstream operations. Single-use technologies include bioreactor bags and mixers, sterile tubing and connectors, sampling assemblies, single-use sensors, depth and sterile filtration units, chromatography flow paths, media and buffer storage bags, and fill-finish fluid management components. Core applications span mammalian cell culture for monoclonal antibodies, recombinant proteins, and vaccines; microbial and cell-based processes in select steps; and increasingly flexible multi-product manufacturing for clinical and commercial supply. End users include biopharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), cell and gene therapy developers, and clinical manufacturing facilities that prioritize speed, contamination control, and rapid changeovers. Single-use adoption is closely linked to facilities aiming to reduce cleaning validation burden, accelerate tech transfer, and support smaller batch sizes and multi-product portfolios with higher scheduling agility.